Considering the endothelial cell-specific nature of SOX17, its role in neovascularization and maintenance of arterial identity, the increase risk of PAH in patients with loss of function mutations in SOX17, strongly suggest that this transcription factor plays a pivotal role in the pathogenesis of the disease. The gene discussed is SOX17; the disease is pulmonary arterial hypertension.